Back to mobile site

Oppenheimer Reiterates Outperform Rating on ESSA Pharma (EPIX)

September 16, 2024 7:56 AM EDT Send to a Friend
Oppenheimer analyst Leland Gershell reiterated an Outperform rating and $17.00 price target on ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login